After the institutional review board approval and written informed consent , forty patients undergoing radical gastrectomy were equally randomized to receive dexmedetomidine infusion ( Dex group ; 0.5 g kg ( -1 ) initial dose followed by a maintenance dose of 0.4 g kg ( -1 ) h ( -1 ) ) or normal saline infusion ( NS group ) .